CVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions
CVS pays $315 million to settle federal claims over illegal opioid dispensing and Controlled Substances Act violations from 2013 to 2025.
Stocks · News reference
Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $112
Leerink Partners analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $119 to $112.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
CVS Agrees To Pay $315M For Illegally Filling Unlawful Opioid Prescriptions And For Submitting False Claims To The Federal Government
https://www.justice.gov/opa/pr/cvs-agrees-pay-315m-illegally-filling-unlawful-opioid-prescriptions-and-submitting-false
'CVS agrees to pay $315 million to settle Justice Department case over opioid prescriptions' - Associated Press